Zhejiang, China

Fang Lei

This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fang Lei. Retrieved from https://idiyas.com/inventor/fang-lei-heqolprq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fang Lei - Innovator in Blood Coagulation Technology

Introduction

Fang Lei is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of biomedical materials, particularly in blood coagulation technologies. His innovative work has the potential to impact medical practices and improve patient outcomes.

Latest Patents

Fang Lei holds a patent for a "Blood coagulation-promoting silk fibroin-polypeptide electrospun membrane and preparation method thereof." This invention discloses a specialized electrospun membrane made from silkworm silk fibroin, enhanced with the polypeptide GPRPPSEHLQIT. The membrane is designed to promote blood coagulation by specifically binding to human fibrinogen, making it a valuable material in medical applications.

Career Highlights

Fang Lei is affiliated with Zhejiang University, where he conducts research and develops innovative solutions in the field of biomedical engineering. His work focuses on creating materials that can effectively address medical challenges, particularly in the area of wound healing and blood coagulation.

Collaborations

Fang Lei collaborates with esteemed colleagues, including Yajun Shuai and Mingying Yang. Together, they contribute to advancing research and development in their respective fields.

Conclusion

Fang Lei's contributions to blood coagulation technology exemplify the importance of innovation in healthcare. His patented work not only showcases his expertise but also holds promise for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…